Recently, researchers have focused on the common links between the c-Abl-mediated regulation of structural changes involving the actin cytoskeleton and organelle dynamics and the transcriptional program activated during synaptic plasticity, with the aim of finding potentially effective treatments to improve degenerative results and delay memory loss in neurodegenerative diseases [42–44]. The gene discussed is ABL1; the disease is neurodegenerative disease.